Comparing the structure and function of the heart’s right and left ventricles. How the 'armpit of Kansas City' landed the ...

The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker ...

Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...

A collaboration of researchers in Switzerland, Germany, and the US tracked cardiac function in recreational marathon runners ...

The use of left-sided Impella microaxial flow pumps has expanded rapidly for the management of cardiogenic shock, left ...

The existing clinical data supporting safety and efficacy of CardiAMP Cell Therapy for HFrEF is subject to ongoing regulatory discussions in Japan and the United States. The compilation includes data ...

Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with ...

Because there’s a silver lining for most things in life, maybe there’s also one for ABC’s craven (if brief) suspension, under thuggish government pressure, of Jimmy Kimmel’s late-night talk show. To ...

Heart failure is a heterogeneous syndrome. Approximately 30–50% of patients with heart failure have normal or near normal left ventricle function. Several epidemiological studies confirm that the ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...